Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiro Fujimura

Showing results (41-50 of 176) with videos related to

Pageof 18
Sort By:
Hepato-Gastroenterology|June 30, 2010
ADAMTS13 activity decreases after hepatectomy, reflecting a postoperative liver dysfunctionEiji Okano, Saiho Ko, Hiromichi Kanehiro, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 18, 2004
[Changes of ADAMTS13 activity and endothelial cell markers in TMA cases]Yoshitaka Mori, Hideo Wada, Hiroshi Shiku, et al.
International Journal of Hematology|January 8, 2010
Pivotal role of ADAMTS13 function in liver diseasesMasahito Uemura, Yoshihiro Fujimura, Saiho Ko, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 22, 2007
[Case of thrombotic thrombocytopenic purpura associated with clopidogrel]Toshihiro Fukusako, Hiroshi Yamashita, Masatoshi Omoto, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2019
Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and HMasaki Hayakawa, Seiji Kato, Taei Matsui, et al.
Japanese Journal of Clinical Oncology|November 23, 2006
Successful treatment of primitive neuroectodermal tumor-associated microangiopathy with multiple bone metastasesToru Morishita, Masanori Matsumoto, Kanya Honoki, et al.
Internal Medicine (Tokyo, Japan)|April 8, 2010
Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitorNobuharu Kosugi, Yuya Tsurutani, Ayami Isonishi, et al.
The Journal of Obstetrics and Gynaecology Research|August 14, 2013
Case of maternal and fetal deaths due to severe congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) during pregnancyHirokazu Tanaka, Chiaki Tenkumo, Nobuhiro Mori, et al.
Transfusion|June 11, 2015
Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasmaAyami Isonishi, Charles L Bennett, Barbara Plaimauer, et al.
Transfusion|May 14, 2017
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusionsYumi Yoshii, Yoshihiro Fujimura, Charles L Bennett, et al.
Pageof 18

Showing results (41-50 of 176) with videos related to

Sort By:
Pageof 18
Hepato-Gastroenterology|June 30, 2010
ADAMTS13 activity decreases after hepatectomy, reflecting a postoperative liver dysfunctionEiji Okano, Saiho Ko, Hiromichi Kanehiro, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 18, 2004
[Changes of ADAMTS13 activity and endothelial cell markers in TMA cases]Yoshitaka Mori, Hideo Wada, Hiroshi Shiku, et al.
International Journal of Hematology|January 8, 2010
Pivotal role of ADAMTS13 function in liver diseasesMasahito Uemura, Yoshihiro Fujimura, Saiho Ko, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 22, 2007
[Case of thrombotic thrombocytopenic purpura associated with clopidogrel]Toshihiro Fukusako, Hiroshi Yamashita, Masatoshi Omoto, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2019
Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and HMasaki Hayakawa, Seiji Kato, Taei Matsui, et al.
Japanese Journal of Clinical Oncology|November 23, 2006
Successful treatment of primitive neuroectodermal tumor-associated microangiopathy with multiple bone metastasesToru Morishita, Masanori Matsumoto, Kanya Honoki, et al.
Internal Medicine (Tokyo, Japan)|April 8, 2010
Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitorNobuharu Kosugi, Yuya Tsurutani, Ayami Isonishi, et al.
The Journal of Obstetrics and Gynaecology Research|August 14, 2013
Case of maternal and fetal deaths due to severe congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) during pregnancyHirokazu Tanaka, Chiaki Tenkumo, Nobuhiro Mori, et al.
Transfusion|June 11, 2015
Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasmaAyami Isonishi, Charles L Bennett, Barbara Plaimauer, et al.
Transfusion|May 14, 2017
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusionsYumi Yoshii, Yoshihiro Fujimura, Charles L Bennett, et al.
Pageof 18